Vaxcyte, Inc. (PCVX)
65.25
+1.63
(+2.56%)
USD |
NASDAQ |
Oct 19, 14:43
Vaxcyte Cash from Operations (Annual) : -655.58M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -655.58M |
| December 31, 2024 | -452.63M |
| December 31, 2023 | -296.79M |
| December 31, 2022 | -170.60M |
| Date | Value |
|---|---|
| December 31, 2021 | -121.39M |
| December 31, 2020 | -46.63M |
| December 31, 2019 | -48.24M |
| December 31, 2018 | -30.47M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Moderna, Inc. | -1.873B |
| Vir Biotechnology, Inc. | -391.78M |
| Revolution Medicines, Inc. | -897.74M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |